Disclosed is a locator for the fill-port of apparatus implanted under a patent's skin and connected by a flow tube to a breast-implanted tissue-expanding pouch. The embedded apparatus includes a circular metallic base and a dome-shaped self-sealing septum that is adapted for engagement by a syringe needle for injection of saline solution for filling the pouch. The locator is metallic and has a circular opening for engaging the patient's skin above the dome septum.

An information bearing septum viewable under radiographic imaging is formed by molding a septum base to have a depression with a given configuration and molding a one-piece solid radiopaque material insert having the same given configuration. The radiopaque insert is mounted to the cavity formed by the depression at the septum base. The top of the septum is then covered by a silicone layer that bonds to the septum. The finished septum is adapted to be fitted to a reservoir housing of a subcutaneous implantable portal. In place of the solid insert, the septum may be formed by placing on top of the septum base a one-piece top layer impregnated with a radiopaque material that has an integral hanging insert that fittingly mounts into the cavity formed by the depression at the septum base.

The device includes a manipulation mechanism for maneuvering a base into position proximate a subcutaneous port. Arms extending from the base enable the device to receive the port and substantially immobilize the port relative to the device. The manipulation mechanism also enables a user to substantially immobilize the device relative to a patient. With the subcutaneous port substantially immobilized by the device, the user has greater confidence and accuracy when inserting a needle into the port. Further, embodiments of the device provide protection to the user to prevent inadvertent sticking of the user as the needle is introduced.

Improvements for use with tissue expanders are provided. A tissue expander includes: a selectively inflatable and deflatable shell that is configured to be implanted; and an access port for selectively inflating and deflating the shell, the access port comprising a sidewall, a base at a first end, and a membrane at a second end opposite the first end, wherein the sidewall and the base of the access port are constructed of a material that is non-reactive with a magnetic resonance imaging (MRI) machine. In embodiments, the tissue expander includes a magnet at the access port. In embodiments, the magnet is configured with a physical size and magnetic force such that, when the tissue expander is implanted, the magnet is detectable by an external magnetometer sensor but is not detectable by an external dangle-magnet.

An insertion device to assist in accessing an access port that has been subcutaneously implanted in the body of a patient is disclosed. The implanted access port is accessed by a needle of a needle assembly, such as a needle-based infusion set. The insertion device may include a body having a stabilizing portion and a guide portion. The stabilizing portion stabilizes a position of the implanted access port when the body is placed on the skin of the patient atop the implanted access port. The guide portion is designed to guide a needle of the needle assembly along a predetermined path such that the needle transcutaneously pierces a septum of the implanted access port.

A device is described for the transcutaneous location of an intracorporeally, subcutaneously located medical implant, which has an implant surface on which at least one electrical coil is arranged. The coil has at least one coil winding enclosing a region of the implant surface, together with an extracorporeally operable unit, to which at least one electrical coil is fitted, which is adapted in shape and size to the electrical coil arranged on the implant, and which is connected to an electrical control unit and to a signalling means, which generates a perceptible signal, at least in the case of maximum inductive coupling between the two electrical coils.

Endovascular drug delivery systems and methods are disclosed herein for delivering a therapeutic agent to the intracranial subarachnoid space of a patient, and/or deploying an endovascular drug delivery device distal portion in the intracranial subarachnoid space and a portion of the drug delivery device body in a dural venous sinus such that a therapeutic agent is delivered from the deployed drug delivery device into the intracranial subarachnoid space.

An inflatable port including a housing, a chamber in the housing, a septum over the chamber, a hollow stem extending from the housing, and a bladder around at least a portion of the housing. The chamber has a major opening and a minor opening. The septum is positioned over the major opening of the chamber and is fixed to the housing. The stem fluidly connects to the chamber by way of the minor opening of the chamber. The bladder is configured to increase a size of the inflatable port upon inflation of the bladder and decrease the size of the inflatable port upon deflation of the bladder. Also disclosed herein is a catheter assembly including the inflatable port, as well as a method related to the foregoing inflatable port and catheter assembly.